Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter

被引:5
|
作者
Bonnet, JJ [1 ]
机构
[1] IFRMP, UMR CNRS 6036, Lab Neuropsychopharmacol Expt, F-76000 Rouen, France
关键词
DAT (dopamine transporter); cation; anion; binding; uptake blocker;
D O I
10.1016/j.ejphar.2003.08.069
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Uptake blockers and substrates are likely to recognise a common binding domain on the dopamine neuronal transporter (DAT). Among cations that form ionic gradients at the level of the cellular plasma membrane, Na+ is the only one that can stimulate their binding. The binding stimulation appears over Na+ concentrations ranging from 0 to 10-60 mM; at higher Na+ concentrations, binding reaches a plateau or decreases, according to the uptake blocker that is studied. The majority of the other cations, including K+, Ca2+, Mg2+ and Tris(+), inhibit the binding of uptake blockers. Several metals impair binding to the DAT and/or the dopamine transport, but, under specific conditions, some of them, and chiefly Zn2+, stimulate binding. The complex relationships between cations, uptake blockers and the DAT suggest that cations recognise at least three different sites: the first one, site 1, is for cation-induced binding inhibition; the second one, site 2, is for Na+-induced binding stimulation; and the third one, site 3, is for Zn2+-induced binding stimulation. Modelling of the interactions between Na+, K+ and radioligands allows a better understanding of the effects of cations at sites 1 and 2, and of uptake blockers at site 1. Some anions also facilitate the binding of uptake blockers to the DAT, as far as they are associated with Na+. The dependence of the binding of dopamine on ions could be involved in its preferential inward transport and used by uptake blockers for their own binding to the DAT. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:199 / 212
页数:14
相关论文
共 50 条
  • [21] Tyrosine hydroxylase immunohistochemistry, dopamine transporter binding and effects of the dopamine uptake inhibitor GBR 12909 in mutant dystonic hamsters
    Richter, A
    Gernert, M
    Löscher, W
    Jiwa, D
    Raymond, R
    Nobrega, JN
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (04) : R791 - R791
  • [22] The effects of alkyl substituents at the 6-position of cocaine analogues on dopamine transporter binding affinity and dopamine uptake inhibition
    Lomenzo, SA
    Izenwasser, S
    Katz, JL
    Trudell, ML
    MEDICINAL CHEMISTRY RESEARCH, 1998, 8 (1-2) : 35 - 42
  • [23] Dopamine uptake and cocaine binding mechanisms: The involvement of charged amino acids from the transmembrane domains of the human dopamine transporter
    Dar, DE
    Metzger, TG
    Vandenbergh, DJ
    Uhl, GR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 538 (1-3) : 43 - 47
  • [24] Methylation of the Dopamine Transporter Gene as a Biomarker for Dopamine Transporter Binding in Unmedicated ADHD Patients
    Wiers, Corinde
    Lohoff, Falk
    Muench, Christine
    Shumay, Elena
    Swanson, James
    Wang, Gene-Jack
    Volkow, Nora
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S299 - S299
  • [25] TRICYCLIC ANTIDEPRESSANTS AND CALCIUM-CHANNEL BLOCKERS - INTERACTIONS AT THE (-)-DESMETHOXYVERAPAMIL BINDING-SITE AND THE SEROTONIN TRANSPORTER
    REHAVI, M
    CARMI, R
    WEIZMAN, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (1-2) : 1 - 9
  • [26] Interactions of novel methylphenidate derivatives with the dopamine transporter
    Schweri, MM
    Ye, X
    Ojo, B
    Deutsch, HM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R175 - R175
  • [27] Sparing of serotonin and norepinephrine transporter uptake compared to dopamine transporter uptake in early Parkinson's disease
    Marek, K.
    Jennings, D.
    Russell, D.
    Batis, J.
    Tamagnan, G.
    Seibyl, J.
    MOVEMENT DISORDERS, 2009, 24 : S199 - S199
  • [28] Dopamine transporter binding in social phobia.
    Schneier, FR
    Martinez, D
    Zhu, Z
    Huang, Y
    Liebowitz, MR
    Laruelle, M
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 37P - 37P
  • [29] Dopamine transporter binding in Wilson's disease
    Huang, CC
    Chu, NS
    Yen, TC
    Wai, YY
    Lu, CS
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2003, 30 (02) : 163 - 167
  • [30] Serotonin and dopamine transporter binding in children with autism
    McDougle, Christopher J.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2008, 50 (08): : 565 - 565